Using 'dead or dependent' as an outcome measure in parkinson's disease clinical trials
Conclusion
‘Death or dependency’ is a feasible and potentially important new composite outcome measure for PD trials, including neuroprotective trials, although more work needs to be done to confirm this.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: McGhee, D., Parker, A., Fielding, S., Counsell, C. Tags: Drugs: CNS (not psychiatric), Parkinson's disease, Stroke Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23-24 October 2013 Source Type: research
More News: Brain | Clinical Trials | Neurology | Neurosurgery | Parkinson's Disease | Psychiatry | Royal College of Physicians | Stroke | Study